QT IMAGING HOLDINGS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
QT IMAGING HOLDINGS, INC. (QTI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 42.27 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- QT IMAGING HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 41.45M shares, a 10.55% increase year-over-year.
- QT IMAGING HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 37.49M shares, a 14.84% decline year-over-year.
- QT IMAGING HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 44.03M shares, a 2108.05% increase year-over-year.
- QT IMAGING HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 1.99M shares.
- QT IMAGING HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 36.84M shares, a 103.85% increase from fiscal 2024.
- QT IMAGING HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 18.07M shares, a 388.91% increase from fiscal 2023.
- QT IMAGING HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.70M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 42.27M shares 10-Q · filed 2026-08-12 | |||||||
| 2026-03-31 | 41.45M shares 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | 36.84M shares 10-K · filed 2026-03-25 | |||||||
| 2025-09-30 | 33.61M shares 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | 38.54M shares 10-Q · filed 2026-08-12 | 115.63M shares 10-Q · filed 2025-08-07 | ||||||
| 2025-03-31 | 37.49M shares 10-Q · filed 2026-05-13 | 112.48M shares 10-Q · filed 2025-05-13 | ||||||
| 2024-12-31 | 18.07M shares 10-K · filed 2026-03-25 | 54.49M shares 10-K · filed 2025-03-31 | ||||||
| 2024-09-30 | 15.36M shares 10-Q · filed 2025-11-12 | 46.09M shares 10-Q · filed 2024-11-13 | ||||||
| 2024-06-30 | 45.51M shares 10-Q · filed 2025-08-07 | |||||||
| 2024-03-31 | 44.03M shares 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | 3.70M shares 10-K · filed 2025-03-31 | |||||||
| 2023-09-30 | 2.27M shares 10-Q · filed 2024-11-13 | |||||||
| 2023-06-30 | 2.00M shares 10-Q · filed 2024-08-08 | |||||||
| 2023-03-31 | 1.99M shares 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |